Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 166 entries
Sorted by: Best Match Show Resources per page
Influence of wheat germ and β-glucan on some chemical and sensory properties of Turkish noodle.

Journal of food science and technology

Aktaş K, Bilgiçli N, Levent H.
PMID: 26345028
J Food Sci Technol. 2015 Sep;52(9):6055-60. doi: 10.1007/s13197-014-1677-z. Epub 2014 Dec 14.

Wheat flour used in Turkish noodle (erişte) production was replaced with wheat germ (0, 10, 20 and 30 %) and β-glucan (0 and 4 %). Noodle samples were analyzed for their moisture, ash, protein, fat, mineral contents, color values...

Cite
Aktaş K, Bilgiçli N, Levent H. Influence of wheat germ and β-glucan on some chemical and sensory properties of Turkish noodle. J Food Sci Technol. 2014;52(9):6055-60doi: 10.1007/s13197-014-1677-z.
Aktaş, K., Bilgiçli, N., & Levent, H. (2015). Influence of wheat germ and β-glucan on some chemical and sensory properties of Turkish noodle. Journal of food science and technology, 52(9), 6055-60. https://doi.org/10.1007/s13197-014-1677-z
Aktaş, Kübra, et al. "Influence of wheat germ and β-glucan on some chemical and sensory properties of Turkish noodle." Journal of food science and technology vol. 52,9 (2015): 6055-60. doi: https://doi.org/10.1007/s13197-014-1677-z
Aktaş K, Bilgiçli N, Levent H. Influence of wheat germ and β-glucan on some chemical and sensory properties of Turkish noodle. J Food Sci Technol. 2015 Sep;52(9):6055-60. doi: 10.1007/s13197-014-1677-z. Epub 2014 Dec 14. PMID: 26345028; PMCID: PMC4554671.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Zannad F, Maugendre P, Audry A, Avril C, Blaise L, Blin O, Burnel P, Falise-Mirat B, Girault D, Giri I, Goehrs JM, Lassale C, Le Meur R, Leurent P, Ratignier-Carbonneil C, Rossignol P, Satonnet E, Simon P, Treluyer L.
PMID: 27393227
Therapie. 2014 Jul-Aug;69(4):339-46. doi: 10.2515/therapie/2014042.

No abstract available.

Cite
Zannad F, Maugendre P, Audry A. Télémédecine : quel cadre, quels niveaux de preuves, quelles modalités de déploiement. [Not Available]. Therapie. 2014;69(4):339-46doi: 10.2515/therapie/2014042.
Zannad, F., Maugendre, P., Audry, A., Avril, C., Blaise, L., Blin, O., Burnel, P., Falise-Mirat, B., Girault, D., Giri, I., Goehrs, J. M., Lassale, C., Le Meur, R., Leurent, P., Ratignier-Carbonneil, C., Rossignol, P., Satonnet, E., Simon, P., & Treluyer, L. (2014). Télémédecine : quel cadre, quels niveaux de preuves, quelles modalités de déploiement. [Not Available]. Therapie, 69(4), 339-46. https://doi.org/10.2515/therapie/2014042
Zannad, Faiez, et al. "Télémédecine : quel cadre, quels niveaux de preuves, quelles modalités de déploiement." [Not Available]. Therapie vol. 69,4 (2014): 339-46. doi: https://doi.org/10.2515/therapie/2014042
Zannad F, Maugendre P, Audry A, Avril C, Blaise L, Blin O, Burnel P, Falise-Mirat B, Girault D, Giri I, Goehrs JM, Lassale C, Le Meur R, Leurent P, Ratignier-Carbonneil C, Rossignol P, Satonnet E, Simon P, Treluyer L. Télémédecine : quel cadre, quels niveaux de preuves, quelles modalités de déploiement. [Not Available]. Therapie. 2014 Jul-Aug;69(4):339-46. doi: 10.2515/therapie/2014042. French. PMID: 27393227.
Copy Download .nbib Format: NLM
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Molecular psychiatry

Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Marciniak E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, Hamdane M, Humez S, Müller CE, Lopes LV, Buée L, Blum D.
PMID: 26216297
Mol Psychiatry. 2016 Jan;21(1):149. doi: 10.1038/mp.2015.115. Epub 2015 Jul 28.

No abstract available.

Cite
Laurent C, Burnouf S, Ferry B, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry. 2015;21(1):149doi: 10.1038/mp.2015.115.
Laurent, C., Burnouf, S., Ferry, B., Batalha, V. L., Coelho, J. E., Baqi, Y., Malik, E., Marciniak, E., Mariciniak, E., Parrot, S., Van der Jeugd, A., Faivre, E., Flaten, V., Ledent, C., D'Hooge, R., Sergeant, N., Hamdane, M., Humez, S., Müller, C. E., Lopes, L. V., Buée, L., & Blum, D. (2016). A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular psychiatry, 21(1), 149. https://doi.org/10.1038/mp.2015.115
Laurent, C, et al. "A2A adenosine receptor deletion is protective in a mouse model of Tauopathy." Molecular psychiatry vol. 21,1 (2016): 149. doi: https://doi.org/10.1038/mp.2015.115
Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Marciniak E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, Hamdane M, Humez S, Müller CE, Lopes LV, Buée L, Blum D. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry. 2016 Jan;21(1):149. doi: 10.1038/mp.2015.115. Epub 2015 Jul 28. PMID: 26216297.
Copy Download .nbib Format: NLM
Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum.

FEBS open bio

Strøm TB, Tveten K, Laerdahl JK, Leren TP.
PMID: 24918045
FEBS Open Bio. 2014 Mar 19;4:321-7. doi: 10.1016/j.fob.2014.03.007. eCollection 2014.

More than 1700 mutations in the low density lipoprotein receptor (LDLR) gene have been found to cause familial hypercholesterolemia (FH). These are commonly divided into five classes based upon their effects on the structure and function of the LDLR....

Cite
Strøm TB, Tveten K, Laerdahl JK, et al. Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum. FEBS Open Bio. 2014;4:321-7doi: 10.1016/j.fob.2014.03.007.
Strøm, T. B., Tveten, K., Laerdahl, J. K., & Leren, T. P. (2014). Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum. FEBS open bio, 4321-7. https://doi.org/10.1016/j.fob.2014.03.007
Strøm, Thea Bismo, et al. "Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum." FEBS open bio vol. 4 (2014): 321-7. doi: https://doi.org/10.1016/j.fob.2014.03.007
Strøm TB, Tveten K, Laerdahl JK, Leren TP. Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum. FEBS Open Bio. 2014 Mar 19;4:321-7. doi: 10.1016/j.fob.2014.03.007. eCollection 2014. PMID: 24918045; PMCID: PMC4048843.
Copy Download .nbib Format: NLM
Benign paroxysmal positional vertigo after radiologic scanning: a case series.

Journal of medical case reports

Aydin E, Akman K, Yerli H, Ozluoglu LN.
PMID: 18371218
J Med Case Rep. 2008 Mar 27;2:92. doi: 10.1186/1752-1947-2-92.

INTRODUCTION: Benign paroxysmal positional vertigo (BPPV) is the most common type of vertigo. It is frequently seen in elderly patients, and the course of the attack may easily mimic cerebrovascular disease. A BPPV attack after a radiologic examination has...

Cite
Aydin E, Akman K, Yerli H, et al. Benign paroxysmal positional vertigo after radiologic scanning: a case series. J Med Case Rep. 2008;2:92doi: 10.1186/1752-1947-2-92.
Aydin, E., Akman, K., Yerli, H., & Ozluoglu, L. N. (2008). Benign paroxysmal positional vertigo after radiologic scanning: a case series. Journal of medical case reports, 292. https://doi.org/10.1186/1752-1947-2-92
Aydin, Erdinc, et al. "Benign paroxysmal positional vertigo after radiologic scanning: a case series." Journal of medical case reports vol. 2 (2008): 92. doi: https://doi.org/10.1186/1752-1947-2-92
Aydin E, Akman K, Yerli H, Ozluoglu LN. Benign paroxysmal positional vertigo after radiologic scanning: a case series. J Med Case Rep. 2008 Mar 27;2:92. doi: 10.1186/1752-1947-2-92. PMID: 18371218; PMCID: PMC2324108.
Copy Download .nbib Format: NLM
In Vivo Confocal Microscopy in Presumed Central Cloudy Dystrophy of François.

Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye

Utine CA, Oral D, Altunsoy M, Basar D, Alimgil LM.
PMID: 20337272
Ophthalmic Surg Lasers Imaging. 2010 Mar 09;1-4. doi: 10.3928/15428877-20100216-02. Epub 2010 Mar 09.

A 70-years-old woman with no visual symptoms was incidentally diagnosed with presumed central cloudy dystrophy of François (CCDF) on regular ophthalmic examination. Bilateral polygonal opacities separated by clear spaces were seen in corneal biomicroscopic examination. The opacities were prominent...

Cite
Utine CA, Oral D, Altunsoy M, et al. In Vivo Confocal Microscopy in Presumed Central Cloudy Dystrophy of François. Ophthalmic Surg Lasers Imaging. 2010;1-4doi: 10.3928/15428877-20100216-02.
Utine, C. A., Oral, D., Altunsoy, M., Basar, D., & Alimgil, L. M. (2010). In Vivo Confocal Microscopy in Presumed Central Cloudy Dystrophy of François. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye, 1-4. https://doi.org/10.3928/15428877-20100216-02
Utine, Canan Asli, et al. "In Vivo Confocal Microscopy in Presumed Central Cloudy Dystrophy of François." Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye vol. (2010): 1-4. doi: https://doi.org/10.3928/15428877-20100216-02
Utine CA, Oral D, Altunsoy M, Basar D, Alimgil LM. In Vivo Confocal Microscopy in Presumed Central Cloudy Dystrophy of François. Ophthalmic Surg Lasers Imaging. 2010 Mar 09;1-4. doi: 10.3928/15428877-20100216-02. Epub 2010 Mar 09. PMID: 20337272.
Copy Download .nbib Format: NLM
Words of wisdom. Re: Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.

European urology

Turkeri LN.
PMID: 22640861
Eur Urol. 2012 Jul;62(1):184-5. doi: 10.1016/j.eururo.2012.04.015.

No abstract available.

Cite
Turkeri LN. Words of wisdom. Re: Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol. 2012;62(1):184-5doi: 10.1016/j.eururo.2012.04.015.
Turkeri, L. N. (2012). Words of wisdom. Re: Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. European urology, 62(1), 184-5. https://doi.org/10.1016/j.eururo.2012.04.015
Turkeri, Levent N. "Words of wisdom. Re: Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis." European urology vol. 62,1 (2012): 184-5. doi: https://doi.org/10.1016/j.eururo.2012.04.015
Turkeri LN. Words of wisdom. Re: Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol. 2012 Jul;62(1):184-5. doi: 10.1016/j.eururo.2012.04.015. PMID: 22640861.
Copy Download .nbib Format: NLM
Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy.

Indian journal of dermatology

Aydin F, Levent Y, Nilgun S, Pancar YE, Yasar TA.
PMID: 22121263
Indian J Dermatol. 2011 Sep-Oct;56(5):501-4. doi: 10.4103/0019-5154.87130.

BACKGROUND: The underlying molecular basis of mycosis fungoides (MF) has not yet been clarified. However, defects in apoptosis may contribute to its pathogenesis.AIM: We investigated the expression of Bax, Fas, and p53 in early-stage MF patients and any alterations...

Cite
Aydin F, Levent Y, Nilgun S, et al. Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy. Indian J Dermatol. 2011;56(5):501-4doi: 10.4103/0019-5154.87130.
Aydin, F., Levent, Y., Nilgun, S., Pancar, Y. E., & Yasar, T. A. (2011). Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy. Indian journal of dermatology, 56(5), 501-4. https://doi.org/10.4103/0019-5154.87130
Aydin, Fatma, et al. "Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy." Indian journal of dermatology vol. 56,5 (2011): 501-4. doi: https://doi.org/10.4103/0019-5154.87130
Aydin F, Levent Y, Nilgun S, Pancar YE, Yasar TA. Implications of bax, fas, and p53 in the pathogenesis of early-stage mycosis fungoides and alterations in expression following photochemotherapy. Indian J Dermatol. 2011 Sep-Oct;56(5):501-4. doi: 10.4103/0019-5154.87130. PMID: 22121263; PMCID: PMC3221208.
Copy Download .nbib Format: NLM
How Can New Imaging Modalities Help in the Practice of Radiology?.

The Eurasian journal of medicine

Pirimoglu B, Sade R, Ogul H, Kantarci M, Eren S, Levent A.
PMID: 28149149
Eurasian J Med. 2016 Oct;48(3):213-221. doi: 10.5152/eajm.2016.0260.

The purpose of this article was to provide an up-to-date review on the spectrum of new imaging applications in the practice of radiology. New imaging techniques have been developed with the objective of obtaining structural and functional analyses of...

Cite
Pirimoglu B, Sade R, Ogul H, et al. How Can New Imaging Modalities Help in the Practice of Radiology?. Eurasian J Med. 2016;48(3):213-221doi: 10.5152/eajm.2016.0260.
Pirimoglu, B., Sade, R., Ogul, H., Kantarci, M., Eren, S., & Levent, A. (2016). How Can New Imaging Modalities Help in the Practice of Radiology?. The Eurasian journal of medicine, 48(3), 213-221. https://doi.org/10.5152/eajm.2016.0260
Pirimoglu, Berhan, et al. "How Can New Imaging Modalities Help in the Practice of Radiology?." The Eurasian journal of medicine vol. 48,3 (2016): 213-221. doi: https://doi.org/10.5152/eajm.2016.0260
Pirimoglu B, Sade R, Ogul H, Kantarci M, Eren S, Levent A. How Can New Imaging Modalities Help in the Practice of Radiology?. Eurasian J Med. 2016 Oct;48(3):213-221. doi: 10.5152/eajm.2016.0260. PMID: 28149149; PMCID: PMC5268606.
Copy Download .nbib Format: NLM
The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial.

Global pediatric health

van Haselen R, Thinesse-Mallwitz M, Maidannyk V, Buskin SL, Weber S, Keller T, Burkart J, Klement P.
PMID: 27493984
Glob Pediatr Health. 2016 Jul 04;3:2333794X16654851. doi: 10.1177/2333794X16654851. eCollection 2016.

We investigated the clinical effectiveness of a homeopathic add-on therapy in a pediatric subpopulation with upper respiratory tract infections (URTI) in a randomized, controlled, multinational clinical trial. Patients received either on-demand symptomatic standard treatment (ST-group) or the same ST...

Cite
van Haselen R, Thinesse-Mallwitz M, Maidannyk V, et al. The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial. Glob Pediatr Health. 2016;3:2333794X16654851doi: 10.1177/2333794X16654851.
van Haselen, R., Thinesse-Mallwitz, M., Maidannyk, V., Buskin, S. L., Weber, S., Keller, T., Burkart, J., & Klement, P. (2016). The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial. Global pediatric health, 32333794X16654851. https://doi.org/10.1177/2333794X16654851
van Haselen, Robert, et al. "The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial." Global pediatric health vol. 3 (2016): 2333794X16654851. doi: https://doi.org/10.1177/2333794X16654851
van Haselen R, Thinesse-Mallwitz M, Maidannyk V, Buskin SL, Weber S, Keller T, Burkart J, Klement P. The Effectiveness and Safety of a Homeopathic Medicinal Product in Pediatric Upper Respiratory Tract Infections With Fever: A Randomized Controlled Trial. Glob Pediatr Health. 2016 Jul 04;3:2333794X16654851. doi: 10.1177/2333794X16654851. eCollection 2016. PMID: 27493984; PMCID: PMC4959794.
Copy Download .nbib Format: NLM
Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Orphanet journal of rare diseases

Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D.
PMID: 27387831
Orphanet J Rare Dis. 2016 Jul 07;11(1):92. doi: 10.1186/s13023-016-0463-6.

No abstract available.

Cite
Attarian S, Vallat JM, Magy L, et al. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2016;11(1):92doi: 10.1186/s13023-016-0463-6.
Attarian, S., Vallat, J. M., Magy, L., Funalot, B., Gonnaud, P. M., Lacour, A., Péréon, Y., Dubourg, O., Pouget, J., Micallef, J., Franques, J., Lefebvre, M. N., Ghorab, K., Al-Moussawi, M., Tiffreau, V., Preudhomme, M., Magot, A., Leclair-Visonneau, L., Stojkovic, T., Bossi, L., Lehert, P., Gilbert, W., Bertrand, V., Mandel, J., Milet, A., Hajj, R., Boudiaf, L., Scart-Grès, C., Nabirotchkin, S., Guedj, M., Chumakov, I., & Cohen, D. (2016). Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet journal of rare diseases, 11(1), 92. https://doi.org/10.1186/s13023-016-0463-6
Attarian, Shahram, et al. "Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A." Orphanet journal of rare diseases vol. 11,1 (2016): 92. doi: https://doi.org/10.1186/s13023-016-0463-6
Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2016 Jul 07;11(1):92. doi: 10.1186/s13023-016-0463-6. PMID: 27387831; PMCID: PMC4937550.
Copy Download .nbib Format: NLM
Clinical pregnancy following GnRH agonist administration in the luteal phase of fresh or frozen assisted reproductive technology (ART) cycles: Systematic review and meta-analysis.

European journal of obstetrics & gynecology and reproductive biology: X

Chau LTM, Tu DK, Lehert P, Dung DV, Thanh LQ, Tuan VM.
PMID: 31403130
Eur J Obstet Gynecol Reprod Biol X. 2019 May 13;3:100046. doi: 10.1016/j.eurox.2019.100046. eCollection 2019 Jul.

OBJECTIVES: To study if the GnRH agonist administration in luteal phase improves clinical pregnancy rate of fresh and frozen embryo transfer. Also, this meta-analysis compares the treatment effect of luteal GnRH agonist administration between long agonist and antagonist protocols...

Cite
Chau LTM, Tu DK, Lehert P, et al. Clinical pregnancy following GnRH agonist administration in the luteal phase of fresh or frozen assisted reproductive technology (ART) cycles: Systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100046doi: 10.1016/j.eurox.2019.100046.
Chau, L. T. M., Tu, D. K., Lehert, P., Dung, D. V., Thanh, L. Q., & Tuan, V. M. (2019). Clinical pregnancy following GnRH agonist administration in the luteal phase of fresh or frozen assisted reproductive technology (ART) cycles: Systematic review and meta-analysis. European journal of obstetrics & gynecology and reproductive biology: X, 3100046. https://doi.org/10.1016/j.eurox.2019.100046
Chau, Le Thi Minh, et al. "Clinical pregnancy following GnRH agonist administration in the luteal phase of fresh or frozen assisted reproductive technology (ART) cycles: Systematic review and meta-analysis." European journal of obstetrics & gynecology and reproductive biology: X vol. 3 (2019): 100046. doi: https://doi.org/10.1016/j.eurox.2019.100046
Chau LTM, Tu DK, Lehert P, Dung DV, Thanh LQ, Tuan VM. Clinical pregnancy following GnRH agonist administration in the luteal phase of fresh or frozen assisted reproductive technology (ART) cycles: Systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol X. 2019 May 13;3:100046. doi: 10.1016/j.eurox.2019.100046. eCollection 2019 Jul. PMID: 31403130; PMCID: PMC6687475.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 166 entries